Males and females of reproductive potential must agree to use an effective contraceptive method during the treatment, and after the end of treatment: during twelve months for women, taking into account the characteristics of rituximab

Complete initial work-up within 8 days prior to treatment that allows definite staging.

Able to comply with scheduled follow-up and with management of toxicity.

Signed informed consent from patients and/or their parents or legal guardians